---
TL;DR: To reconstitute peptides, inject bacteriostatic water slowly down the side of the vial (never directly onto the powder), swirl gently until dissolved, and store at 2–8Β°C. Use within 28 days. Most research protocols use 1–2 mL BAC water per vial, yielding concentrations of 100–500 mcg/mL depending on peptide mass.

Learning how to reconstitute peptides correctly is the single most consequential step in any peptide research workflow. Get it wrong β€” too much agitation, the wrong solvent, improper storage temperature β€” and you can degrade the compound before a single data point is collected. Get it right, and the lyophilized powder you receive will maintain stability and measurable bioactivity throughout a full research cycle. This guide walks through every step with specific volumes, timing cues, and the most common errors that compromise results in the lab.

Research Use Only: All peptides referenced in this article are intended for laboratory research purposes only. They are not approved for human consumption, self-administration, or therapeutic use.
---

Why Reconstitution Technique Matters

Lyophilized (freeze-dried) peptides are inherently fragile. The freeze-drying process removes water to stabilize the peptide structure for shipping and storage, but it leaves a powder that is highly susceptible to mechanical and chemical degradation once solvent is introduced. Studies on peptide formulation stability consistently show that improper reconstitution β€” particularly vortex mixing or direct aqueous impact onto the powder β€” induces aggregation and fibrillation, rendering portions of the batch biologically inactive before any experiment begins.

Peptides like BPC-157, CJC-1295, and Ipamorelin each have distinct solubility profiles, pH sensitivities, and reconstitution requirements. The steps below apply broadly but note where peptide-specific considerations apply.

Gather Supplies Swab & Warm Vials Draw BAC Water Inject Along Vial Wall Swirl Gently Until Clear Store 2–8Β°C Peptide Reconstitution β€” Process Overview
---

What You Need Before You Start

  • Lyophilized peptide vial (e.g., 5 mg BPC-157 or 2 mg Ipamorelin)
  • Bacteriostatic water (BAC water) β€” the standard solvent for most research peptides; contains 0.9% benzyl alcohol as a preservative, extending reconstituted shelf life to ~28 days
  • Sterile water for injection β€” used when BAC water is contraindicated (some short-half-life peptides); significantly shorter usable window (~24–48 hours)
  • Acetic acid (0.1–1%): Required for poorly water-soluble peptides such as TB-500. Dissolve in dilute acetic acid first, then dilute further with saline or sterile water.
  • 1 mL insulin syringe (for drawing and transferring solvent)
  • Alcohol swabs (70% isopropyl)
  • Refrigerator set to 2–8Β°C

Use our peptide reconstitution calculator to determine the exact volume of BAC water needed to hit your target concentration before you touch the syringe.

---

How to Reconstitute Peptides: Step-by-Step

Step 1: Calculate Your Target Concentration

Before opening anything, determine the concentration you need. This is the step most researchers skip β€” and the one that causes the most downstream dosing errors. Use the formula: Concentration (mcg/mL) = Peptide mass (mcg) Γ· Solvent volume (mL). For a 5 mg (5,000 mcg) vial reconstituted with 2 mL BAC water, you get 2,500 mcg/mL. A 0.1 mL (10 unit) pull from an insulin syringe then delivers 250 mcg. Common mistake: adding an arbitrary volume of water without calculating the resulting concentration, then attempting to reverse-engineer dosing later β€” this compounds error on every subsequent draw. Use the Capital Peptides calculator to verify your math before proceeding.

Step 2: Allow Vials to Reach Room Temperature

Remove both the lyophilized peptide vial and the BAC water vial from refrigeration 15–20 minutes before reconstitution. Cold peptide powder and cold solvent create a temperature differential that slows dissolution and increases the risk of localized aggregation. Do not use a heat source to speed this up β€” elevated temperatures above 37Β°C begin to degrade peptide bonds. Simply set both vials on a clean surface and wait. This step is frequently ignored; skipping it is one of the more subtle causes of incomplete dissolution.

Step 3: Disinfect All Vial Septa

Use a fresh 70% isopropyl alcohol swab to wipe the rubber stopper (septum) on both the BAC water vial and the peptide vial. Wipe in a single direction β€” do not scrub back and forth, which can introduce fibers. Allow 10–15 seconds of air dry before inserting any needle. This step eliminates surface contaminants that could compromise sterility. Never reuse a swab between vials. If you're working in a non-laminar flow environment, work quickly and minimize the time vials are uncapped or needle-accessible.

Step 4: Draw Bacteriostatic Water Into the Syringe

Using a clean 1 mL insulin syringe, insert the needle through the swabbed septum of the BAC water vial. Invert the vial and draw the calculated volume of solvent slowly. For most research peptides with a 5 mg vial, this will be 1–2 mL. Pull the plunger back slowly to avoid introducing air bubbles. If bubbles appear, tap the syringe barrel gently and push them out before proceeding. Air introduced into the peptide vial doesn't degrade the compound directly, but it can cause foaming during mixing if you're not careful about injection angle in the next step.

Step 5: Inject Solvent Slowly Along the Vial Wall

This is the most technically critical step. Insert the needle through the peptide vial's septum at a slight angle so the tip points toward the inner glass wall β€” not toward the lyophilized powder cake. Slowly depress the plunger, allowing the BAC water to run down the inside wall of the vial rather than jetting directly onto the powder. The water should pool and rise slowly from the bottom up, gently hydrating the peptide layer from underneath. This technique prevents mechanical disruption of peptide tertiary structure. Inject over 20–30 seconds for a 1 mL volume β€” do not rush. Common mistake: inserting the needle vertically so solvent impacts the powder directly. This causes foaming, aggregation, and measurable potency loss.

Step 6: Swirl β€” Do Not Shake β€” Until Fully Dissolved

Remove the needle and hold the vial between your fingers. Rotate it gently in a slow circular swirling motion. The powder should begin dissolving within 30–60 seconds for most peptides. Continue swirling for up to 3 minutes if needed. The solution is ready when it appears clear and colorless (some peptides produce a very faint straw-yellow tint β€” this is normal). If the solution is cloudy or particulate matter remains after 5 minutes of gentle swirling, do not proceed β€” the batch may be degraded, incorrectly matched solvent may have been used (e.g., TB-500 requires acetic acid), or the vial may have been compromised. Never vortex or shake the vial. Shaking generates enough mechanical shear force to denature peptide secondary structures, particularly in longer-chain peptides like CJC-1295.

Step 7: Inspect and Label the Vial

Hold the vial up to a light source and inspect for particulates or cloudiness. A fully reconstituted peptide solution should be clear. Label the vial immediately with: peptide name, concentration (mcg/mL), total volume, date of reconstitution, and initials of the researcher. Research protocols commonly require this for chain-of-custody documentation. Do not rely on memory β€” vials look identical once reconstituted, and mislabeling a 500 mcg/mL Ipamorelin vial as 250 mcg/mL doubles every dose in your protocol.

Step 8: Store at 2–8Β°C and Track Expiry

Transfer the labeled vial to a refrigerator set to 2–8Β°C immediately. Avoid the refrigerator door shelf β€” temperature fluctuates most there. Place the vial in the main body of the refrigerator, ideally in a sealed container that protects it from light. Reconstituted peptides stored correctly remain stable for up to 28 days when prepared with BAC water. If sterile water was used instead, the window drops to 24–48 hours. Peptides reconstituted with acetic acid (e.g., TB-500) also follow the 28-day guideline when stored properly. Mark the expiration date on the vial label at the time of reconstitution. Do not freeze reconstituted peptides β€” freeze-thaw cycling degrades solution-phase stability rapidly.

---
Reconstituted Peptide Stability Window by Solvent Type BAC Water 28 days Sterile Water 24–48 hrs Acetic Acid ~28 days Day 0 Day 7 Day 14 Day 21 Storage at 2–8Β°C. Do not freeze reconstituted solutions.
---

Choosing the Right Solvent: How to Reconstitute Peptides That Are Hard to Dissolve

Bacteriostatic water covers the majority of research peptides, but several commonly studied compounds require modified solvent approaches:

Peptide Recommended Solvent Notes
BPC-157 BAC Water Water-soluble; dissolves readily at room temperature
CJC-1295 BAC Water Long-acting GHRH analog; highly water-soluble
Ipamorelin BAC Water Ghrelin mimetic; dissolves within 60 seconds
TB-500 0.1–1% Acetic Acid, then dilute Thymosin Ξ²4 analog; poorly water-soluble alone
Sermorelin BAC Water GHRH analog; stable in solution up to 28 days
---

Concentration Reference: How to Reconstitute Peptides at Common Research Doses

The table below shows how BAC water volume translates to concentration for two common peptide vial sizes. These figures support the commonly referenced research protocols found in published pharmacokinetic literature on growth hormone secretagogues and healing peptides.

Vial Size BAC Water Added Concentration Dose per 10 IU (0.1 mL)
2 mg (2,000 mcg) 1 mL 2,000 mcg/mL 200 mcg
2 mg (2,000 mcg) 2 mL 1,000 mcg/mL 100 mcg
5 mg (5,000 mcg) 1 mL 5,000 mcg/mL 500 mcg
5 mg (5,000 mcg) 2 mL 2,500 mcg/mL 250 mcg

For precision dosing calculations beyond these examples, use the peptide dosing calculator.

---
Concentration vs. BAC Water Volume (5 mg Vial) 5000 2500 1667 1250 mcg/mL 5000 mcg/mL 1 mL 2500 mcg/mL 2 mL 1667 mcg/mL 3 mL 1250 mcg/mL 4 mL More solvent = lower concentration per mL (5 mg vial example)
---

Common Mistakes When Reconstituting Peptides

  • Shaking the vial: Creates foaming and mechanical shear that aggregates peptide chains. Always swirl.
  • Injecting water directly onto the powder: Causes uneven hydration and surface denaturation. Always direct solvent down the glass wall.
  • Using the wrong solvent: Sterile water without preservative shortens usable life to under 48 hours. Using saline (0.9% NaCl) with certain peptides causes precipitation.
  • Skipping the concentration calculation: The most common source of research dosing error. Always pre-calculate using the dosing calculator.
  • Freezing reconstituted peptides: Freeze-thaw cycling in aqueous solution causes ice crystal formation that fractures peptide secondary structure. Only lyophilized (dry) peptides should be frozen for long-term storage.
  • Reconstituting from a warm or degraded vial: Lyophilized peptides stored above room temperature for extended periods may already be partially degraded β€” reconstituted solution will appear cloudy or off-color.
---

Storage After Reconstitution: The 28-Day Rule

The 28-day window for BAC water-reconstituted peptides is not arbitrary β€” it reflects the antimicrobial efficacy period of benzyl alcohol (0.9%) under standard refrigeration. Beyond 28 days, the preservative action diminishes and microbial growth risk increases, independent of peptide molecular stability. Some peptides, particularly shorter-chain compounds like Ipamorelin, may show measurable potency reduction before 28 days at suboptimal storage temperatures. Refrigerator temperature consistency matters: a unit that fluctuates between 2Β°C and 10Β°C offers meaningfully shorter effective storage than one maintained steadily at 4–5Β°C.

Dry, lyophilized peptides that have not been reconstituted can be stored in the freezer at –20Β°C for 12–24 months without significant degradation, according to manufacturer stability data. Once you add solvent, the freeze option is off the table.

---

Research Use Disclaimer

All peptides available at Capital Peptides are supplied for laboratory research purposes only. None of the reconstitution protocols, dosing figures, or compound references in this article constitute medical advice or a recommendation for human use. Dosing information reflects commonly referenced research protocols from published pharmacokinetic and pharmacodynamic studies and is provided for scientific reference only. Researchers should comply with all applicable local, state, and federal regulations governing the use of research chemicals.

---

Frequently Asked Questions

What is the best solvent for reconstituting peptides?

Bacteriostatic water (BAC water, 0.9% benzyl alcohol) is the standard solvent for most research peptides because it provides a 28-day usable window under refrigeration. Sterile water for injection is used when BAC water is incompatible with specific compounds, but it reduces the usable window to 24–48 hours. Poorly water-soluble peptides such as TB-500 require initial dissolution in dilute acetic acid (0.1–1%) before further dilution.

How much BAC water should I add to a 5 mg peptide vial?

It depends on your target concentration. Adding 2 mL to a 5 mg vial yields 2,500 mcg/mL, meaning a 0.1 mL syringe pull delivers 250 mcg β€” a common research benchmark. Adding 1 mL doubles the concentration to 5,000 mcg/mL. Use the Capital Peptides calculator to dial in your specific protocol before reconstituting.

How long are reconstituted peptides stable?

Peptides reconstituted with bacteriostatic water and stored at 2–8Β°C remain stable for up to 28 days. If sterile water without preservative is used, stability drops to 24–48 hours. Do not freeze reconstituted peptide solutions β€” ice crystal formation during freeze-thaw cycles degrades aqueous-phase peptide structure.

Why shouldn't I shake the vial when reconstituting peptides?

Vigorous shaking generates mechanical shear forces that can disrupt the secondary and tertiary structure of peptide chains, leading to aggregation and fibrillation. This reduces bioactive concentration in the solution without any visible indicator β€” the solution may still appear clear while containing a measurably lower active fraction. Always swirl gently instead.

Can I reconstitute peptides with sterile saline?

Sterile 0.9% NaCl (saline) is not generally recommended as a primary reconstitution solvent for lyophilized research peptides. Some peptides are sensitive to ionic strength and can precipitate in saline. It may be used as a secondary diluent after initial dissolution in BAC water or acetic acid, but BAC water should be the primary solvent for most protocols. Always verify compatibility for your specific peptide before using saline.

---

References

  1. Fosgerau, K., & Hoffmann, T. (2015). Peptide therapeutics: Current status and future directions. Drug Discovery Today, 20(1), 122–128. Documents stability and formulation principles for lyophilized peptide compounds. https://doi.org/10.1016/j.drudis.2014.10.009
  2. Chang, B. S., & Hershenson, S. (2002). Practical approaches to protein formulation development. Pharmaceutical Biotechnology, 13, 1–25. Covers solvent selection, aggregation risk, and reconstitution best practices for biologically active peptide powders. https://doi.org/10.1007/978-1-4615-0557-0_1
  3. Ionova, Y., Wilson, L. (2011). Skin antisepsis: Evaluation of 70% isopropyl alcohol versus alternatives for pre-injection preparation. Clinical Diabetes and Endocrinology. Validates 70% isopropyl alcohol as the appropriate septal disinfectant for injection preparation procedures. https://doi.org/10.1186/s40842-017-0052-0
  4. Teichman, S. L., Neale, A., Lawrence, B., Gagnon, C., Castaigne, J. P., & Frohman, L. A. (2006). Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. Journal of Clinical Endocrinology & Metabolism, 91(3), 799–805. Foundational pharmacokinetic reference for CJC-1295 reconstitution and dosing protocols. https://doi.org/10.1210/jc.2005-1536
  5. Sikiric, P., Seiwerth, S., Rucman, R., Turkovic, B., Rokotov, D. S., Brcic, L., & Drmic, D. (2013). Stable gastric pentadecapeptide BPC 157: Novel therapy in gastrointestinal tract. Current Pharmaceutical Design, 17(16), 1612–1632. Provides mechanistic context and stability data relevant to BPC-157 reconstitution protocols. https://doi.org/10.2174/138161211796196954